A new type of therapy that "edits" a gene in patients with a rare heart condition has been shown to be safe and effective, ...

Discover how inebilizumab reduces flares and improves remission rates in IgG4-related disease in this phase 3 clinical trial.

A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

A drug in advanced development for myasthenia gravis also showed promise as a treatment for primary Sjögren's syndrome, a ...

SpyGlass Pharma completed enrollment in a Phase 1/2 trial evaluating its drug delivery platform for glaucoma and ocular ...

Failing to receive the RMAT designation from the FDA for its early-stage Batten disease gene therapy, Neurogene tells ...

Indianapolis-based OrthoIndy treated the first patients with Theradaptive's OsteoAdapt SP spinal fusion implant as part of an ongoing clinical trial. The Phase I/II Oasis trial is asssing the safety ...

Discover six bispecific antibody companies developing a two-in-one approach to delivering targeted therapeutics to patients.

A small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's ...

Basel, November 19, 2024 – Novartis has ranked first in the 2024 Access to Medicine Index (ATMI) report published today, highlighting the company’s leadership in improving access to medicines around ...

Ocugen has announced positive Phase 1 trial results for OCU410, a one-time gene therapy for geographic atrophy secondary to ...